|
Match
|
Document |
Document Title |
|
|
US20090274650 |
INHIBITORS OF ASPARTYL PROTEASE
The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors...
|
|
|
US20090270428 |
CYCLOPROPANECARBOXYLATE ESTERS OF ACYCLOVIR
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, methods of using the same, processes for preparing the same, and intermediates thereof.
|
|
|
US20090270429 |
ANTIVIRAL FORMULATION
A topical antiviral composition comprising acyclovir, penciclovir and/or omaciclovir in a glucocorticoid-free pharmaceutical carrier comprising 15 to 25 weight % propylene glycol and 10 to 25...
|
|
|
US20090258843 |
Compositions Containing Antiviral Compounds and Methods of Using the Same
The present invention is directed to compositions and methods for the treatment of various diseases, pathological disorders, and medical conditions such as viral infections and cancer. The...
|
|
|
US20090180980 |
Anti-Arenaviral Compunds
Described herein are 4-methyl-piperazine-1-carbothioic acid amide derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral infections and...
|
|
|
US20090175928 |
Lip Plaster
The invention relates to a self-adhesive lip plaster which comprises at least one single-layered matrix and which contains at least one antiviral active medical substance for using in the event of...
|
|
|
US20090169511 |
Mucosal Bioadhesive SLow Release Carrier for Delivering Active Principles
A mucosal bioadhesive slow release carrier comprising an active principle and devoid of starch, lactose, which can release the active principal for a duration of longer than 20 hours. This...
|
|
|
US20090130214 |
Gemcitabine derivatives nanoparticles
The invention concerns a 2′,2′-difluoro-2′-deoxycytidine derivative of general formula (I), wherein: R 1 , R 2 and R 3 , identical or different, represent independently of one another, a...
|
|
|
US20090124639 |
VALACYCLOVIR FORMULATIONS
The present invention relates to valacyclovir formulations having improved bioavailability resulting in better efficacy and/or requiring less frequent administration.
|
|
|
US20090118168 |
TOPICAL ADMINSTRATION OF ACYCLOVIR
The present invention provides a topical composition comprising (a) at least one delivery agent compound and (b) a acyclovir compound. Methods of treatment, and methods of preparing the topical...
|
|
|
US20090099154 |
Pharmaceutical Sustained Release Compositions and Processes Thereof
Pharmaceutical sustained release composition comprising at least one active agent(s), or its tautomeric forms, analogues, isomers, polymorphs, solvates, or salts thereof; preferably an antiviral...
|
|
|
US20090099060 |
Modulation of line-1 reverse transcriptase
A reverse transcriptase encoded by L-1 (LINE-1) has been identified as a target molecule for treating or preventing cancers induced or mediated by this molecule. Method of treating or preventing...
|
|
|
US20090099216 |
NOVEL ADENINE COMPOUND
A novel adenine compound represented by the formula (1):
wherein Z represents (un)substituted alkylene, a single bond, etc.; R 1 represents an (un)substituted alkyl, alkenyl, alkynyl,...
|
|
|
US20090076039 |
DEUTERIUM-ENRICHED VALACYCLOVIR
The present application describes deuterium-enriched valacyclovir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
|
|
|
US20090076040 |
DEUTERIUM-ENRICHED VALGANCICLOVIR
The present application describes deuterium-enriched valganciclovir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
|
|
|
US20090074707 |
Shaped body and method for production of said body
Water-dispersible or water-soluble polymers, particularly those of the family of compounds comprising the poloxamers or the polyesters or amphiphilic agents (emulsifiers), and also lipophilic...
|
|
|
US20090062315 |
Pharmaceutical Acceptable Composition Containing Non-Steroidal Anti-Inflammatory Drug and Local Anesthetics
A pharmaceutical acceptable composition is provided. The composition comprises an effective amount of a non-steroidal anti-inflammatory drug (NSAID), a local anesthetic, and an antiviral drug.
|
|
|
US20080299220 |
HYDROPHILIC, NON-AQUEOUS PHARMACEUTICAL CARRIERS AND COMPOSITIONS AND USES
A waterless composition suitable for delivery of an active agent to a body surface or cavity includes a vehicle having about 70% to about 99% by weight of a hydrophilic polar solvent, said...
|
|
|
US20080274164 |
Atrium Patch
The invention relates to a plaster composition for administering active agents in and to bodily orifices, such as e.g. the buccal cavity, lips or genitalia.
|
|
|
US20080260844 |
Solid, Oral, Microparticulate Dosage Form Which Has Been Designed To Prevent Misuse
The invention relates to the field of solid, oral, microparticulate dosage forms having a composition that prevents the misuse of the active pharmaceutical ingredient contained therein. The aim of...
|
|
|
US20080220079 |
SUSTAINED RELEASE COMPOSITIONS USING WAX-LIKE MATERIALS
Sustained release spherical or non-spherical pellets comprising (a) an active ingredient (b) a wax-like agent, and (c) a spheronizing agent are provided. Oral dosage forms comprising said pellets...
|
|
|
US20080213403 |
Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
The present invention provides a method for treating a pulmonary disease state in mammals by protecting indigenous in vivo levels of nitric oxide in mammalian cells comprising contacting the...
|
|
|
US20080181944 |
Dosage Form Comprising Therapeutic Formulation
A dosage form is disclosed comprising a semipermeable walled container that houses a capsule, which capsule comprises a drug formulation, a piston, and an osmotic composition. The dosage form...
|
|
|
US20080132527 |
Compositions For Delivering Acyclovir
The present invention relates to an acyclovir formulation having improved bioavailability resulting in better efficacy and/or requiring less frequent administration.
|
|
|
US20080063673 |
METHOD AND KIT FOR TREATMENT/PREVENTION OF HAIR LOSS
The method includes the steps of cleansing of the scalp sufficiently to remove material which would otherwise block antiviral medication from reaching hair follicles, heating the scalp to increase...
|
|
|
US20080003250 |
NOVEL THERAPY FOR HERPESVIRUS INFECTION
The present invention relates to an implantable drug delivery device comprising a polymeric or polymeric containing material in combination with a therapeutic compound effective for the treatment...
|